Snyder Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.5M Buy
181,107
+6,848
+4% +$1.04M 0.58% 56
2025
Q1
$26.2M Sell
174,259
-3,668
-2% -$552K 0.57% 58
2024
Q4
$32.8M Buy
177,927
+24,086
+16% +$4.45M 0.69% 50
2024
Q3
$30.3M Buy
153,841
+18,198
+13% +$3.58M 0.63% 55
2024
Q2
$28M Sell
135,643
-2,503
-2% -$517K 0.63% 54
2024
Q1
$37.4M Sell
138,146
-9,196
-6% -$2.49M 0.8% 45
2023
Q4
$34.8M Sell
147,342
-7,492
-5% -$1.77M 0.78% 47
2023
Q3
$30.3M Sell
154,834
-534
-0.3% -$105K 0.68% 53
2023
Q2
$32.7M Sell
155,368
-6,980
-4% -$1.47M 0.7% 52
2023
Q1
$32.8M Buy
162,348
+12,147
+8% +$2.45M 0.7% 54
2022
Q4
$32.7M Sell
150,201
-2,292
-2% -$499K 0.74% 51
2022
Q3
$30M Sell
152,493
-3,503
-2% -$689K 0.77% 50
2022
Q2
$33.4M Buy
155,996
+29,987
+24% +$6.42M 0.9% 36
2022
Q1
$35.8M Buy
126,009
+3,848
+3% +$1.09M 0.91% 36
2021
Q4
$46M Sell
122,161
-14,873
-11% -$5.6M 1.11% 33
2021
Q3
$56.6M Buy
137,034
+18,631
+16% +$7.69M 1.5% 26
2021
Q2
$43.8M Sell
118,403
-13,329
-10% -$4.93M 1.23% 30
2021
Q1
$38.2M Sell
131,732
-1,139
-0.9% -$330K 1.1% 34
2020
Q4
$33.2M Sell
132,871
-943
-0.7% -$236K 1.09% 35
2020
Q3
$30.3M Sell
133,814
-2,238
-2% -$507K 1.3% 29
2020
Q2
$23.7M Sell
136,052
-429
-0.3% -$74.8K 1.07% 31
2020
Q1
$17.2M Buy
136,481
+21,242
+18% +$2.68M 0.98% 32
2019
Q4
$17.6M Buy
115,239
+31,107
+37% +$4.75M 0.69% 49
2019
Q3
$11.1M Buy
84,132
+11,687
+16% +$1.55M 0.49% 58
2019
Q2
$10.3M Sell
72,445
-1,494
-2% -$212K 0.46% 58
2019
Q1
$10.7M Buy
73,939
+2,835
+4% +$412K 0.51% 55
2018
Q4
$8.05M Sell
71,104
-5,853
-8% -$662K 0.44% 58
2018
Q3
$10.4M Buy
76,957
+6,233
+9% +$839K 0.46% 56
2018
Q2
$7.94M Buy
70,724
+4,765
+7% +$535K 0.38% 57
2018
Q1
$7.04M Sell
65,959
-1,320
-2% -$141K 0.35% 56
2017
Q4
$7.36M Buy
67,279
+13,866
+26% +$1.52M 0.37% 57
2017
Q3
$5.77M Sell
53,413
-2,637
-5% -$285K 0.29% 57
2017
Q2
$5.67M Buy
+56,050
New +$5.67M 0.3% 56